Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Sales | 14,804 | 9,019 | 0 | 0 | 0 |
Gross Profit | 14,804 | 9,019 | N/A | N/A | N/A |
Operating Expenses | 107,539 | 61,246 | 45,278 | 29,656 | 23,957 |
Operating Income | -92,735 | -52,227 | -45,278 | -29,656 | -23,957 |
Other Income | 3,083 | 368 | 399 | 1,202 | 168 |
Pre-tax Income | -89,652 | -51,859 | -44,879 | -28,454 | -23,789 |
Income Tax | 1,099 | -9,050 | -618 | N/A | N/A |
Net Income Continuous | -90,751 | -42,809 | -44,261 | -28,454 | -23,789 |
Net Income | $-90,751 | $-42,809 | $-44,261 | $-28,454 | $-23,789 |
EPS Basic Total Ops | -47.78 | -28.93 | -30.85 | -21.73 | -40.82 |
EPS Basic Continuous Ops | -47.78 | -28.95 | -30.85 | -21.75 | -40.80 |
EPS Diluted Total Ops | -47.78 | -28.93 | -30.85 | -21.73 | -40.82 |
EPS Diluted Continuous Ops | -47.78 | -28.95 | -30.85 | -21.75 | -40.80 |
EPS Diluted Before Non-Recurring Items | -47.78 | N/A | N/A | N/A | N/A |
EBITDA(a) | $-92,321 | $-52,008 | $-45,198 | $-29,591 | $-23,946 |